Pro Test Diagnostics AB
Pro Test Diagnostics AB is a Swedish biotechnology company developing a proprietary LC-MS/MS diagnostic test kit to detect autologous blood doping, targeting WADA-accredited anti-doping laboratories and international sports federations, currently in validation phase pending WADA approval.
- Company typePrivate
- Founded2006
- HeadquartersUmeå, Sweden
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pro Test Diagnostics AB does
Pro Test Diagnostics AB is a privately-held Swedish biotechnology company headquartered at the Umeå Biotech Incubator in Umeå, Sweden. Founded in 2012 (with underlying research originating in 2006 at Umeå University under Professor Christer Malm), the company is developing a diagnostic test kit for autologous blood doping, the practice of athletes re-infusing their own stored blood to enhance endurance performance. The company's core technology is a liquid chromatography and tandem mass spectrometry (nano-ULC-MS/MS) proteomics assay that analyzes molecular fingerprint changes in red blood cells resulting from long-term cryopreservation, enabling direct discrimination between doped and clean athletes without confounders such as high-altitude training. The kit is supported by a HemoVoid-based sample preparation workflow licensed from Biotech Support Group LLC, with mass spectrometry instrumentation from Waters Corporation and ISO-certified pilot manufacturing handled by Minerva-Biolabs GmbH.
The product targets a tightly defined buyer base: WADA-accredited anti-doping laboratories, private anti-doping labs, international sports federations including the IOC, and testing agencies. Commercial revenue has not yet commenced; the company is in validation phase pending WADA approval, which it identifies as the gating event for market launch. An AI-powered blood cell pre-sorting add-on is in development with 2025 WADA grant funding, intended to enhance detection throughput and sensitivity. The go-to-market motion is direct enterprise field sales led by CEO Anders Mannelqvist, a former Olympic biathlete, with current pilot evaluations underway at the Norwegian Doping Control Laboratory at Oslo University Hospital and the Doping Control Laboratory at Karolinska University Hospital Stockholm. Total external capital raised to date is approximately SEK 18.2 million (USD ~1.75 million equivalent), comprising a SEK 17M equity round in May 2020 (Nascent Invest AB and Fort Knox Förvaring AB) and a SEK 1.2M WADA grant in August 2025.
Pro Test Diagnostics AB firmographics
Firmographics- Name
- Pro Test Diagnostics AB
- Legal name
- Pro Test Diagnostics AB
- Website
- https://protestdx.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Pro Test Diagnostics AB is a Swedish biotechnology company developing a proprietary LC-MS/MS diagnostic test kit to detect autologous blood doping, targeting WADA-accredited anti-doping laboratories and international sports federations, currently in validation phase pending WADA approval.
- Ownership category
- akta.pro rank
Pro Test Diagnostics AB industry classification
Industry- Product category
- Anti-doping diagnostic test kits
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (54138)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Proteomics & Mass Spectrometry Services (HLAGANAB)
- akta.pro secondary industries
- Proteomics & Biomarker Analytical Testing (HLAGADAG), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Pro Test Diagnostics AB is headquartered
LocationHeadquarters
- HQ city
- Umeå
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Pro Test Diagnostics AB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Anti-doping Test Kits: Sale of diagnostic test kits for detection of autologous blood doping to WADA accredited laboratories and private laboratories. Currently in validation phase before market launch.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B diagnostic test kits for anti-doping laboratories |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Pro Test Diagnostics AB product offering
Product offeringCore offering
Pro Test Diagnostics AB develops and sells diagnostic test kits for the direct detection of autologous blood doping in athletes. The core product is a proteomics-based test kit that uses nano-UPLC-MS/MS to analyse molecular fingerprints and unique biomarkers in blood that change when red blood cells have been cryopreserved and later re-transfused. The kit is sold to WADA-accredited and private anti-doping laboratories and sports organisations, with an AI-powered enhancement under development.
Product overview
Pro Test Diagnostics AB offers a single unified diagnostic product: an autologous blood doping test kit. The core product is a test kit that detects whether athletes have used their own blood for doping by identifying molecular fingerprint changes that occur when blood is stored frozen. The kit uses nano-UPLC-MS/MS based proteomics to measure unique biomarkers for long-term freeze storage of red blood cells. An AI-powered blood analysis system is under development as an enhancement to improve detection by pre-sorting blood cells and identifying subtle abnormalities. The test is designed for reliability and ease of use in WADA accredited and private anti-doping laboratories.
Differentiator
Problem solved
Functional benefit
Products and services
- Autologous Blood Doping Test Kit A diagnostic test kit that detects autologous blood doping by analysing molecular fingerprints in blood that change when blood is stored frozen outside the body. Uses liquid chromatography and tandem mass spectrometry (LC-MS/MS) based proteomics with HemoVoid-based hemoglobin depletion to identify unique biomarkers for long-term freeze storage of red blood cells. Sold to WADA-accredited and private anti-doping laboratories.
Quantifiable outcome
- Clear separation of doped from clean athletes with no confounding factors
Companies that use Pro Test Diagnostics AB
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Pro Test Diagnostics AB technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Pro Test Diagnostics AB partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and supporting.
- Biotech Support Group LLCcoreSupply agreement for HemoVoid product used for hemoglobin depletion and red cell cytosolic proteome enrichment. Essential for achieving high signal-to-noise ratio in LC-MS/MS analysis.
- Waters CorporationsupportingProvides nano-ACQUITY Ultra Performance UPLC and Synapt G2 mass spectrometry equipment used in the detection method. Waters MS technologies based in Manchester, UK.
- Minerva-Biolabs GmbhsupportingISO certified manufacturing partner that produced the first pilot run of diagnostic kits delivered to Pro Test Diagnostics on July 23rd.
- Umeå Biotech IncubatorsupportingBusiness incubator providing product development support. Company is located at the incubator facility in Umeå.
- Umeå UniversitycoreAcademic research institution where the unique blood doping detection method was developed. Professor Christer Malm is affiliated with the Department of Sports Medicine.
- Norwegian Doping Control Laboratory at Oslo University HospitalsupportingWADA accredited laboratory conducting pilot testing and evaluation of Pro Test Diagnostics kits.
- Doping Control Laboratory at Karolinska University Hospital StockholmsupportingWADA accredited laboratory conducting pilot testing and evaluation of Pro Test Diagnostics kits.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Pro Test Diagnostics AB competitors and assessment
Company assessmentBroad incumbents
- Bruker Corporation: Provider of high-resolution mass spectrometry and proteomics platforms (timsTOF, MALDI-TOF) used in clinical proteomics and doping analysis. Comparable as a broad incumbent in MS-based detection that could expand into the autologous blood doping niche.
- Eurofins Scientific: Global testing services group with pharma and clinical diagnostics laboratories and method development capabilities. Comparable as a potential acquirer or competitor with the scale to commercialize anti-doping assays across multiple geographies and accredit them within its existing lab network.
- SCIEX: Major mass spectrometry vendor supplying triple quadrupole and QTOF systems widely deployed in anti-doping and clinical labs. Comparable as an alternative instrument supplier whose customers are the same WADA-accredited laboratories Pro Test targets, and which offers forensic/anti-doping application kits.
- Waters Corporation: Manufacturer of the nano-ACQUITY UPLC and Synapt G2 mass spectrometers that power Pro Test's detection method. Comparable as both an existing technology partner and a potential competitor that could commercialize its own autologous blood doping application on the same platform.
- Thermo Fisher Scientific: Global leader in mass spectrometry instruments (Orbitrap, TSQ) and consumables widely used in clinical, forensic, and anti-doping LC-MS/MS workflows. Comparable as the dominant incumbent platform whose instruments Pro Test's method could run on, and which could itself develop competing anti-doping kits.
- LGC Group (including HFL Sport Science): UK-based life sciences measurement company operating anti-doping reference materials and the HFL Sport Science anti-doping laboratory (formerly HFL). Comparable because it sells certified reference materials and operates a WADA-accredited lab serving the same anti-doping market as Pro Test Diagnostics.
Direct peers
- RECIPE Chemicals + Instruments GmbH: Develops and manufactures certified reference materials, calibrators, and ready-to-use kits for clinical and forensic toxicology including doping analysis by LC-MS/MS. Comparable because it sells validated MS-based kits into the same anti-doping laboratory channel as Pro Test Diagnostics.
- Seibersdorf Labor GmbH: Operates a WADA-accredited anti-doping laboratory offering screening and confirmation testing using LC-MS/MS. Comparable as a downstream user of MS-based anti-doping kits and a potential reference customer for Pro Test's autologous blood doping assay.
- International Doping Tests & Management (IDTM): Provides doping control sample collection and management services to sports organizations and anti-doping agencies worldwide. Comparable because IDTM is part of the same anti-doping ecosystem and interfaces with WADA-accredited laboratories using detection kits like those Pro Test is developing.
- Chromsystems Instruments & Chemicals GmbH: Mass spectrometry-based reagent kit manufacturer that supplies clinical and forensic toxicology kits, including doping screening reagents to anti-doping labs. Directly comparable as a reagent-kit vendor selling into the same WADA-accredited lab customer base as Pro Test Diagnostics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pro Test Diagnostics AB social profiles
Digital presencePro Test Diagnostics AB financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pro Test Diagnostics AB leadership team
Management profileNumber of profiles
Profiles6 records
Pro Test Diagnostics AB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pro Test Diagnostics AB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pro Test Diagnostics AB
What does Pro Test Diagnostics AB do?
Pro Test Diagnostics AB develops and sells diagnostic test kits for the direct detection of autologous blood doping in athletes. The core product is a proteomics-based test kit that uses nano-UPLC-MS/MS to analyse molecular fingerprints and unique biomarkers in blood that change when red blood cells have been cryopreserved and later re-transfused. The kit is sold to WADA-accredited and private anti-doping laboratories and sports organisations, with an AI-powered enhancement under development.
Is Pro Test Diagnostics AB a public or private company?
Pro Test Diagnostics AB is a private company. It is classified as private equity controlled and is currently operating.
When was Pro Test Diagnostics AB founded?
Pro Test Diagnostics AB was founded in 2006. It employs 1 to 10 people.
Where is Pro Test Diagnostics AB based?
Pro Test Diagnostics AB is headquartered in Umeå, Sweden, in the Europe region.
How does Pro Test Diagnostics AB make money?
One revenue line is on record: anti-doping Test Kits.
Who are Pro Test Diagnostics AB's main competitors?
Broad incumbents on record are Bruker Corporation, Eurofins Scientific, SCIEX, Waters Corporation, Thermo Fisher Scientific and LGC Group (including HFL Sport Science). Direct peers are RECIPE Chemicals + Instruments GmbH, Seibersdorf Labor GmbH, International Doping Tests & Management (IDTM) and Chromsystems Instruments & Chemicals GmbH.
Does Pro Test Diagnostics AB have an API?
No public API is recorded for Pro Test Diagnostics AB.
What industry is Pro Test Diagnostics AB in?
Pro Test Diagnostics AB's product category is Anti-doping diagnostic test kits. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 621511 and its SIC code is 8731.